Comparative efficacy and safety of oral P2Y 12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis.
Ioannis T FarmakisStefanos ZafeiropoulosIoannis DoundoulakisAreti PagiantzaEfstratios KaragiannidisDimitrios V MoysidisNikolaos StalikasGeorge KassimisLampros K MichalisHaralambos KarvounisGeorge GiannakoulasPublished in: Open heart (2022)
In patients with NSTE-ACS intended to receive invasive management, an antiplatelet strategy based on prasugrel is more efficient than a similar strategy based on ticagrelor on a moderate level of evidence. This analysis supports the current recommendations by the ESC guidelines.